March 15, 2022, Vol 327, No. 11, Pages 1011-1100
Prevalence and Durability of SARS-CoV-2 Antibodies Among Unvaccinated US Adults by History of COVID-19
Jennifer L. Alejo, MD; Jonathan Mitchell, MBBS; Amy Chang, MD; et al.
free access has active quiz
JAMA. 2022;327(11):1085-1087. doi:10.1001/jama.2022.1393
This study uses serologic testing to characterize natural immunity and the long-term durability of SARS-CoV-2 antibodies among unvaccinated US adults by history of COVID-19 infection.